Voluntary Recall of Blood Pressure Medicine Losartan
Hilton Perez, M.D
Clinical Director, HoyHealth
Torrent Pharmaceutics issued a voluntary recall due to findings related to small traces of carcinogens
High blood pressure is a chronic condition that affects about 75 million American adults (32%) and is one of the leading causes of heart disease and stroke, and the leading to death in the United States, as reported by the Centers for Disease Control and Prevention, Division for Heart Diseases and Stroke Prevention.
Losartan, a popular angiotensin II receptor blocker (ARB) medication used for the treatment of high blood pressure, a chronic condition, have been under scrutiny by the FDA for containing cancer-causing impurities. Other ARB medications, including valsartan and irbesartan has been recalled as well, due to trace amounts of carcinogens.
Torrent Pharmaceutics began a voluntary recall of the medication in December 2018, due to findings related to small traces of carcinogens. The manufacturer has extended a voluntary recall which affects 3 lots of losartan potassium tablets and 2 lots of losartan/ hydrochlorothiazide tablets.
To determine if your medication has been recalled, check the recalled drug name and manufacturer, before contacting your pharmacy for further advice.
Contact your healthcare provider to determine next steps, as not all losartan products were affected by the recall.
To obtain additional information on this recall, please read the FDA page for updates.